| Product Code: ETC7594119 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Iran Pharmacogenetic Testing Market Overview |
3.1 Iran Country Macro Economic Indicators |
3.2 Iran Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Iran Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Iran Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Iran Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Iran Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Iran Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Iran Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Iran Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Iran Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Iran Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Iran Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about personalized medicine and its benefits |
4.2.2 Growth in chronic diseases requiring personalized treatment |
4.2.3 Supportive government initiatives and policies for precision medicine |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure and resources |
4.3.2 High costs associated with pharmacogenetic testing |
4.3.3 Lack of skilled professionals in the field of pharmacogenomics |
5 Iran Pharmacogenetic Testing Market Trends |
6 Iran Pharmacogenetic Testing Market, By Types |
6.1 Iran Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Iran Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Iran Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Iran Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Iran Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Iran Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Iran Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Iran Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Iran Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Iran Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Iran Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Iran Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Iran Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Iran Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Iran Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Iran Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Iran Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Iran Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Iran Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Iran Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Iran Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Iran Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Iran Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Iran Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Iran Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Iran Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Iran Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Iran Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Iran Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Iran Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Iran Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Iran Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Iran Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Iran Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Iran Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Iran Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Iran Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Iran Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Iran Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Iran Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Iran Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Iran Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Iran Pharmacogenetic Testing Market Export to Major Countries |
7.2 Iran Pharmacogenetic Testing Market Imports from Major Countries |
8 Iran Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Adoption rate of pharmacogenetic testing by healthcare providers |
8.2 Number of research studies and publications related to pharmacogenomics in Iran |
8.3 Investment in research and development for new pharmacogenetic testing technologies |
9 Iran Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Iran Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Iran Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Iran Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Iran Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Iran Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Iran Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Iran Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Iran Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Iran Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Iran Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here